GeneCentic Presents Validation Study of it’s Lung Cancer Gene Expression Subtyping Panel

On November 15, 2014, at the annual Association of Molecular Pathology meeting in Maryland just outside Washington DC, GeneCentric presented a validation study of its Lung Cancer Gene Expression Subtyping Panel (LSP) using RT-qPCR of formalin fixed paraffin embedded samples.

The LSP gene signature has been shown to be a robust method for classifying lung tumors and demonstrates good concordance with morphology classification in multiple datasets. Gene expression profiling may supplement morphologic assessment in lung tumors particular in those that are difficult to classify. Additional details of the poster can be viewed here.